🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine multiple dose safety, tolerabilit...
Status
Completed
Location
Abbott Clinical Pharmaceutical Research Unit
Start Date
2009-04
Trial ID
NCT00890318
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Site Reference ID/Investigator# 41128
Start Date
2010-10
Trial ID
NCT01221298
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01081483
To assess the safety, tolerability and pharmacokinetics of the ABT-072 tabl...
Status
Completed
Location
Site Reference ID/Investigator# 23742
Start Date
2009-09
Trial ID
NCT00982826
This is a follow-up study with no treatment and only samples being collecte...
Status
Completed
Location
Site Reference ID/Investigator# 18222
Start Date
2009-04
Trial ID
NCT00872196
Treatments Being Tested
The purpose of this study is to assess the bioavailability, safety, tolerab...
Status
Completed
Location
Site Reference ID/Investigator# 22384
Start Date
2009-07
Trial ID
NCT00947440
Treatments Being Tested
To evaluate the safety, tolerability and pharmacokinetics of ABT-072 in hea...
Status
Completed
Location
Global Medical Information
Start Date
2008-09
Trial ID
NCT00752687
This study assessed the safety, tolerability, pharmacokinetics, and antivir...
Status
Completed
Location
Site Reference ID/Investigator# 23392
Start Date
2010-03
Trial ID
NCT01074008